The emerging nosocomial pathogens Cryptosporidium, Escherichia coli O157:H7, Helicobacter pylori, and hepatitis C: epidemiology, environmental survival, efficacy of disinfection, and control measures.
New and emerging infectious diseases pose a threat to public health and may be responsible for nosocomial outbreaks. Cryptosporidium parvum and Escherichia coli are gastrointestinal pathogens that have caused nosocomial infections via person-to-person transmission, environmental contamination, or contaminated water or food. Helicobacter pylori has been transmitted via inadequately disinfected endoscopes. Finally, hepatitis C may be acquired by healthcare personnel by percutaneous or mucous membrane exposure to blood or between patients by use of contaminated blood products or via environmental contamination. Rigorous adherence to Standard Precautions, Contact Precautions for patients with infectious diarrhea, disinfection of environmental surfaces, and appropriate disinfection of endoscopes are adequate to prevent nosocomial acquisition of these pathogens.
Weber
D J
DJ
Department of Medicine, University of North Carolina at Chapel Hill, 27599-7030, USA.
Rutala
W A
WA
D000818:Animals; D003140:Communicable Disease Control / Q000379:methods*; D021821:Communicable Diseases, Emerging / Q000382:microbiology* / Q000517:prevention & control*; D003428:Cross Infection / Q000382:microbiology* / Q000517:prevention & control*; D003457:Cryptosporidiosis / Q000453:epidemiology* / Q000517:prevention & control*; D016785:Cryptosporidium parvum; D004927:Escherichia coli Infections / Q000453:epidemiology* / Q000517:prevention & control*; D019453:Escherichia coli O157; D016481:Helicobacter Infections / Q000453:epidemiology* / Q000517:prevention & control*; D016480:Helicobacter pylori; D006526:Hepatitis C / Q000453:epidemiology* / Q000517:prevention & control*; D006801:Humans